Post Subject #124   The company has received positive feedback from the jondoeuk 04/08/22 03:04:20 PM #123   AACR posters https://www.iovance.com/wp-content/uploads/Chesney_IOV-LUN-TiP-post jondoeuk 04/08/22 03:02:37 PM #122   Preclinical data https://www.iovance.com/wp-content/uploads/IovanceBio-ESMO_Post jondoeuk 03/20/22 08:48:50 PM #121   Additional immune checkpoint targets, cytokine tethered TIL, as jondoeuk 03/20/22 08:46:23 PM #120   The company plans to initiate a clinical trial jondoeuk 03/20/22 08:46:13 PM #119   New preclinical data jondoeuk 12/09/21 05:47:56 PM #118   SITC: Title: Phase 2 efficacy and safety of autologous jondoeuk 10/01/21 12:17:23 PM #117   http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:2 Watts Watt 09/23/21 08:48:17 AM #116   Two more https://www.prnewswire.com/news-releases/obsidian-therapeutics--md-ande jondoeuk 09/09/21 03:34:50 PM #115   New paper (clinical data were shared last year jondoeuk 08/13/21 05:04:45 PM #114   Late preclinical programs in IND-enabling studies include a jondoeuk 08/06/21 12:45:26 PM #113   There seems to be both a lack of jondoeuk 07/13/21 07:44:38 PM #112   Thanks. There seems to be both a lack Watts Watt 07/13/21 07:13:26 PM #111   GNCA does not use TIL and gene edit jondoeuk 07/12/21 03:59:22 PM #110   GNCA does not use TIL and gene edit, NY1972 07/11/21 11:10:02 PM #109   For TIL and neoantigen-reactive TCR-T therapies these include, jondoeuk 07/11/21 01:18:29 PM #106   Without any significant news of late, this is Watts Watt 06/24/21 11:15:19 AM #105   https://www.openpr.com/news/2310258/investigation-announced-for-long-term-invest Watts Watt 06/24/21 10:49:10 AM #104   IOVA remains very low compared to its high Watts Watt 06/17/21 11:59:06 AM #103   Who are all the competitors to Iovance in Watts Watt 06/16/21 01:29:45 PM #102   Slides https://ir.iovance.com/static-files/7f1edb46-6a77-4e34-b907-6402f4b5355f jondoeuk 06/06/21 05:46:59 PM #101   Slides from another presentation https://www.iovance.com/wp-content/uploads/Iova jondoeuk 06/06/21 11:41:15 AM #100   Link to the webcast https://edge.media-server.com/mmc/p/kpbeg536 jondoeuk 06/05/21 08:39:01 PM #99   ASCO poster https://www.iovance.com/wp-content/uploads/Iovance_ASCO-2021_COM-202 jondoeuk 06/04/21 11:43:12 AM #98   * * $IOVA Video Chart 05-20-2021 * * ClayTrader 05/20/21 05:06:38 PM #97   * * $IOVA Video Chart 05-19-2021 * * ClayTrader 05/19/21 05:14:20 PM #96   The JCO publishes clinical data for Cohort 2 jondoeuk 05/14/21 04:52:56 PM #95   Posters https://www.iovance.com/wp-content/uploads/AACR_2021_ePoster_IOV-CLL-01_ jondoeuk 04/10/21 03:48:21 PM #94   AACR https://www.abstractsonline.com/pp8/#!/9325/presentation/4856 https://ww jondoeuk 03/10/21 07:04:08 PM #93   Another company working on TIL (and who are jondoeuk 01/20/21 10:11:26 PM #92   JP Morgan webcast https://jpmorgan.metameetings.net/events/healthcare21/sessions jondoeuk 01/20/21 10:10:31 PM #91   SITC poster https://www.iovance.com/wp-content/uploads/SITC-2020-ePoster_IOV-COM jondoeuk 11/10/20 04:32:22 PM #90   The pivotal NSCLC trial has been posted https://clinicaltrials.gov/ct2/show/NCT0 jondoeuk 11/04/20 06:11:47 PM #89   SITC Background: Single agent checkpoint inhibitors (CPI) are an approved jondoeuk 10/14/20 09:11:26 PM #88   * * $IOVA Video Chart 10-06-2020 * * ClayTrader 10/06/20 05:35:10 PM #87   The posters https://www.iovance.com/wp-content/uploads/IovanceBio-ESMO_Poster_1_ jondoeuk 10/06/20 02:39:24 PM #86   The company has pushed back the timeline for jondoeuk 10/05/20 04:35:50 PM #85   ESMO abstracts jondoeuk 09/14/20 05:24:14 PM #84   It is a proof of concept and I jondoeuk 07/15/20 12:09:14 PM #83   The target antigen was shedded in a hurry NY1972 06/25/20 11:12:23 AM #82   Achilles have dosed the first patients https://www.globenewswire.com/news-releas jondoeuk 06/24/20 05:53:07 PM #81   Going forward they could drop Yervoy and expand jondoeuk 06/24/20 05:50:55 PM #80   Some early data in ovarian https://www.oncotarget.com/article/27604/text/ jondoeuk 06/24/20 05:49:40 PM #79   Skip to the 33:30 min mark https://aacr20vm2.onlineeventpro.freeman.com/live-str jondoeuk 06/24/20 05:38:12 PM #78   TODAY is BREAKOUT DAY....for IOVA...if closes above $39.00 Justfactsmam 05/22/20 01:27:43 PM #77   AACR II https://www.abstractsonline.com/pp8/#!/9045/presentation/7075 jondoeuk 05/16/20 12:48:47 PM #76   Great EARNINGS conference call ... Justfactsmam 05/07/20 11:20:48 AM #75   Great EARNINGS conference call ... Justfactsmam 05/07/20 11:20:46 AM #74   Most were PD-L1 low/absent and TMB low. With* jondoeuk 04/30/20 06:53:22 PM #73   Achilles Therapeutics is running two trials in melanoma jondoeuk 04/22/20 09:07:41 PM Post Subject

© 2022 InvestorsHub.com, Inc.